Human leucocytes processed by fast-rate inertial microfluidics retain conventional functional characteristics
Journal of The Royal Society Interface · 2024
DOI: 10.1098/rsif.2023.0572 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of The Royal Society Interface, 2024. Verfasst von Tom Carvell und 5 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biological Chemistry, Biophysics and Bioengineering, School of Engineering and Physical Sciences, Heriot-Watt University, Heriot-Watt Re…. Hauptthemen laut MEDLINE: Leukocytes, Mononuclear, Microfluidics. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Scotland, NHS National Services Scotland.
Abstract (Originalsprache)
The manufacturing of clinical cellular therapies is a complex process frequently requiring manipulation of cells, exchange of buffers and volume reduction. Current manufacturing processes rely on either low throughput open centrifugation-based devices, or expensive closed-process alternatives. Inertial focusing (IF) microfluidic devices offer the potential for high-throughput, inexpensive equipment which can be integrated into a closed system, but to date no IF devices have been approved for use in cell therapy manufacturing, and there is limited evidence for the effects that IF processing has on human cells. The IF device described in this study was designed to simultaneously separate leucocytes, perform buffer exchange and provide a volume reduction to the cell suspension, using high flow rates with high Reynolds numbers. The performance and effects of the IF device were characterized using peripheral blood mononuclear cells and isolated monocytes. Post-processing cell effects were investigated using multi-parameter flow cytometry to track cell viability, functional changes and fate. The IF device was highly efficient at separating CD14+ monocytes (approx. 97% to one outlet, approx. 60% buffer exchange, 15 ml min −1 ) and leucocyte processing was well tolerated with no significant differences in downstream viability, immunophenotype or metabolic activity when compared with leucocytes processed with conventional processing techniques. This detailed approach provides robust evidence that IF devices could offer significant benefits to clinical cell therapy manufacture.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute of Biological Chemistry, Biophysics and Bioengineering, School of Engineering and Physical Sciences, Heriot-Watt University, Heriot-Watt Research Park, Edinburgh EH14 4AS, UK.
- Tissues, Cells and Advanced Therapeutics, Jack Copland Centre, Scottish National Blood Transfusion Service, Research Avenue North, Heriot-Watt Research Park, Edinburgh EH14 4BE, UK.
ORCID-Profile: Tom Carvell
Förderung
- Medical Research Scotland
- NHS National Services Scotland
Zitieren
APA
Carvell, T., Burgoyne, P., Milne, L., Campbell, J. D. M., Fraser, A. R., & Bridle, H. (2024). Human leucocytes processed by fast-rate inertial microfluidics retain conventional functional characteristics. Journal of The Royal Society Interface. https://doi.org/10.1098/rsif.2023.0572
Vancouver
Carvell T, Burgoyne P, Milne L, Campbell JDM, Fraser AR, Bridle H. Human leucocytes processed by fast-rate inertial microfluidics retain conventional functional characteristics. Journal of The Royal Society Interface. 2024. doi:10.1098/rsif.2023.0572
BibTeX
@article{Carvell2024,
author = {Carvell, Tom and Burgoyne, Paul and Milne, Laura and Campbell, John D M and Fraser, Alasdair R and Bridle, Helen},
title = {Human leucocytes processed by fast-rate inertial microfluidics retain conventional functional characteristics},
journal = {Journal of The Royal Society Interface},
year = {2024},
doi = {10.1098/rsif.2023.0572}
}
EUVIMED